MedPath

COCHLEAR MEDICAL DEVICE COMPANY INDIA PRIVATE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

87

Active:6
Completed:58

Trial Phases

1 Phases

Not Applicable:73

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (73 trials with phase data)• Click on a phase to view related trials

Not Applicable
73 (100.0%)

Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients

Not Applicable
Recruiting
Conditions
Hearing Loss, Mixed
Hearing Loss, Conductive
Single-Sided Deafness
Bone Conduction
First Posted Date
2025-09-05
Last Posted Date
2025-09-22
Lead Sponsor
Cochlear
Target Recruit Count
29
Registration Number
NCT07156461
Locations
🇺🇸

Cochlear Americas, Denver Research and Technology Lab, Denver, Colorado, United States

🇦🇺

Cochlear Macquarie, Macquarie University, Sydney, New South Wales, Australia

🇦🇺

HEARnet Clinical Studies, Melbourne, Victoria, Australia

A Pivotal Study to Evaluate the Efficacy and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

Not Applicable
Not yet recruiting
Conditions
Hearing Loss, Bilateral Sensorineural
First Posted Date
2025-08-24
Last Posted Date
2025-09-04
Lead Sponsor
Cochlear
Target Recruit Count
36
Registration Number
NCT07139327
Locations
🇦🇺

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

🇦🇺

Westmead Hospital, Westmead, New South Wales, Australia

🇦🇺

Royal Victoria Eye and Ear Hospital, East Melbourne, Victoria, Australia

and more 2 locations

Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients

Not Applicable
Not yet recruiting
Conditions
Bone Conduction
Hearing Loss, Conductive
Hearing Loss, Mixed
First Posted Date
2025-08-19
Last Posted Date
2025-08-19
Lead Sponsor
Cochlear
Target Recruit Count
18
Registration Number
NCT07130136
Locations
🇬🇧

Countess of Chester Hospital, Chester, United Kingdom

🇬🇧

Royal National Ear, Nose and Throat and Eastman Dental Hospitals, London, United Kingdom

🇬🇧

Nottingham Auditory Implant Programme, Nottingham, United Kingdom

and more 1 locations

Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant Participants

Not Applicable
Recruiting
Conditions
Hearing Loss, Sensorineural
First Posted Date
2025-07-22
Last Posted Date
2025-09-30
Lead Sponsor
Cochlear
Target Recruit Count
20
Registration Number
NCT07077070
Locations
🇺🇸

Cochlear Denver Research Centre, Lone Tree, Colorado, United States

🇧🇪

Cochlear Technology Centre Belgium, Mechelen, Mechelen, Belgium

🇧🇪

European Institute for Otorhinolaryngology (EIORL), ENT Department, Sint-Augustinus Antwerp, Antwerp, Belgium

The Performance of Different Sound Paths in Adult NeuroZti CI-users

Not Applicable
Not yet recruiting
Conditions
Cochlear Implant
Hearing Loss, Bilateral or Unilateral
First Posted Date
2025-06-24
Last Posted Date
2025-08-22
Lead Sponsor
Cochlear
Target Recruit Count
20
Registration Number
NCT07033130
Locations
🇫🇷

Cochlear Vallauris, Vallauris, France

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

News

PolyActiva Secures $40M Series C to Advance Revolutionary Glaucoma Implant Technology

Melbourne-based PolyActiva raised $40 million in Series C funding, including $27 million from Australia's National Reconstruction Fund, to advance its biodegradable glaucoma treatment implant.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.